Imidazole propionate is a driver and therapeutic target in atherosclerosis

by | Jul 16, 2025 | Uncategorized | 0 comments

Author

Nature, Published online: 16 July 2025; doi:10.1038/s41586-025-09263-w

Imidazole propionate produced by gut microbiota is associated with atherosclerosis in mouse models and in humans, and causes the development of atherosclerosis through activation of the imidazoline-1 receptor in myeloid cells.

Archive Posts

0 Comments

Submit a Comment

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.